[Ip-health] IDA Foundation letter of support for LDC waiver extension
kkempton at idafoundation.org
Mon Mar 30 06:14:48 PDT 2015
IDA Foundation, the world's leading not-for-profit supplier of quality-assured essential medicines and medical supplies to low and medium income countries, recently provided a letter of support to the least developed country group of the World Trade Organization. IDA Foundation Managing Director Edwin de Voogd wrote to Ambassador Ahsa of Bangladesh, which is speaking on behalf of the LDCs. The 25 March letter was written in support of the LDC group's request to extend the pharmaceutical waiver as provided in the Doha Declaration on the TRIPS Agreement. The waiver is set to expire on 1 January 2016; the LDC group has requested it be extended until such time as the LDCs transition to developing country status.
In the letter, de Voogd highlighted the importance of the pharmaceutical waiver in assuring continued access to affordable, high-quality medications. He emphasized the value of the waiver beyond the procurement of anti-retrovirals and essential drugs, stating, "it [the waiver] will be relevant for both the production and procurement of products increasingly needed in LDCs, such as those for the treatment of non-communicable diseases".
Along with UNITAID, which recently expressed its support for an extension of the pharmaceutical waiver, IDA Foundation joins those asking that the WTO honor the request made by the LDC members.
For additional information, see the article from IP-Watch:
(If there are questions regarding this submission, please contact me directly.)
Kathryn Kempton | Product Manager HIV/AIDS
IDA Foundation | Making Quality Healthcare Affordable
+31 20 4037196
+31 6 20 599615
+31 20 4031854
kkempton at idafoundation.org<mailto:kkempton at idafoundation.org>
Check your IDA order status online today! Go to: www.idafoundation.org<http://www.idafoundation.org> > login
Disclaimer - "The information contained in this message may be
confidential, and is intended to be exclusively for the addressee.
Should you receive this message unintentionally, please do not use
the contents herein and notify the sender immediately by return e-mail."
More information about the Ip-health